Desensitization for the prevention of drug hypersensitivity reactions
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Drug desensitization is the temporary induction of tolerance to a sensitized drug by administering slow increments of the drug, starting from a very small amount to a full therapeutic dose. It can be used as a therapeutic strategy for patients with drug hypersensitivity when no comparable alternatives are available. Desensitization has been recommended for immunoglobulin E (IgE)-mediated immediate hypersensitivity; however, its indications have recently been expanded to include non-IgE-mediated, non-immunological, or delayed T cell-mediated reactions. Currently, the mechanism of desensitization is not fully understood. However, the attenuation of various intracellular signals in target cells is an area of active research, such as high-affinity IgE receptor (FcεRI) internalization, anti-drug IgG4 blocking antibody, altered signaling pathways in mast cells and basophils, and reduced Ca2+ influx. Agents commonly requiring desensitization include antineoplastic agents, antibiotics, antituberculous agents, and aspirin/nonsteroidal antiinflammatory drugs. Various desensitization protocols (rapid or slow, multi-bag or one-bag, with different target doses) have been proposed for each drug. An appropriate protocol should be selected with the appropriate concentration, dosage, dosing interval, and route of administration. In addition, the protocol should be adjusted with consideration of the severity of the initial reaction, the characteristics of the drug itself, as well as the frequency, pattern, and degree of breakthrough reactions.
Abstract
Drug desensitization is the temporary induction of tolerance to a sensitized drug by administering slow increments of the drug, starting from a very small amount to a full therapeutic dose. It can be used as a therapeutic strategy for patients with drug hypersensitivity when no comparable alternatives are available. Desensitization has been recommended for immunoglobulin E (IgE)-mediated immediate hypersensitivity; however, its indications have recently been expanded to include non-IgE-mediated, non-immunological, or delayed T cell-mediated reactions. Currently, the mechanism of desensitization is not fully understood. However, the attenuation of various intracellular signals in target cells is an area of active research, such as high-affinity IgE receptor (FcεRI) internalization, anti-drug IgG4 blocking antibody, altered signaling pathways in mast cells and basophils, and reduced Ca2+ influx. Agents commonly requiring desensitization include antineoplastic agents, antibiotics, antituberculous agents, and aspirin/nonsteroidal antiinflammatory drugs. Various desensitization protocols (rapid or slow, multi-bag or one-bag, with different target doses) have been proposed for each drug. An appropriate protocol should be selected with the appropriate concentration, dosage, dosing interval, and route of administration. In addition, the protocol should be adjusted with consideration of the severity of the initial reaction, the characteristics of the drug itself, as well as the frequency, pattern, and degree of breakthrough reactions.
참고문헌 (86)
- Demoly P, "International consensus on drug allergy", Allergy, 69, pp.420~437 (2014)
- Mezzano V, "Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy", BioDrugs, 28, pp.133~144 (2014)
- Widal F, "Anaphylaxis and idiosyncrasy. 1992", Allergy Proc, 14, pp.373~376 (1993)
- Peck SM, "Successful desensitization in penicillin sensitivity", J Am Med Assoc, 134, pp.1546~ (1947)
- O’Donovan WJ, "Sensitivity to penicillin : anaphylaxis and desensitisation", Lancet, 2, pp.444~446 (1946)
- Vultaggio A, "Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reaction", J Allergy Clin Immunol Pract, 8, pp.1764~1767 (2020)
- Ang WX, "Mast cell desensitization inhibits calcium flux and aberrantly remodels actin", J Clin Invest, 126, pp.4103~4118 (2016)
- Sancho-Serra Mdel C, "Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization", Eur J Immunol, 41, pp.1004~1013 (2011)
- Mahajan A, "Optimal aggregation of FcεRI with a structurally defined trivalent ligand overrides negative regulation driven by phosphatases", ACS Chem Biol, 9, pp.1508~1519 (2014)
- Shalit M, "Challenge of mast cells with increasing amounts of antigen induces desensitization", Clin Exp Allergy, 25, pp.896~902 (1995)
- Andrews NL, "Small, mobile FcepsilonRI receptor aggregates are signaling competent", Immunity, 31, pp.469~479 (2009)
- Oka T, "Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells", J Allergy Clin Immunol, 132, pp.922~932 (2013)
- Paolini R, "Phosphorylation", dephosphorylation of high-affinity IgE receptors : a mechanism for coupling, Proc Natl Acad Sci U S A, pp.1992, 89[DOI]
- Naclerio R, "Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin", J Allergy Clin Immunol, 71, pp.294~301 (1983)
- Shamji MH, "Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses : novel biomarker of subcutaneous grass pollen immunotherapy", J Allergy Clin Immunol, 143, pp.1067~1076 (2019)
- Shakir EM, "Mechanisms of immunotherapy : a historical perspective", Ann Allergy Asthma Immunol, 105, pp.340~347 (2010)
- Macglashan D, "Loss of syk kinase during IgE-mediated stimulation of human basophils", J Allergy Clin Immunol, 114, pp.1317~1324 (2004)
- Odom S, "Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase", J Exp Med, 199, pp.1491~1502 (2004)
- Katz HR, "Inhibitory receptors and allergy", Curr Opin Immunol, 14, pp.698~704 (2002)
- Katz HR, "Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells", Mol Immunol, 38, pp.1301~1305 (2002)
- Lu-Kuo JM, "gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization", J Biol Chem, 274, pp.5791~5796 (1999)
- Folkerts J, "Effect of dietary fiber and metabolites on mast cell activation and mast cell-associated diseases", Front Immunol, 9, pp.1067~ (2018)
- Vultaggio A, "Mechanisms of drug desensitization : not only mast cells", Front Pharmacol, 11, pp.590991~ (2020)
- Teraki Y, "Successful desensitization to fixed drug eruption : the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization", Dermatology, 209, pp.29~32 (2004)
- Aydogan M, "Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome : increase in number of Treg cells after desensitization", J Allergy Clin Immunol, 132, pp.478~480 (2013)
- Tuzer C, "Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels", Allergy, 75, pp.2942~2945 (2020)
- David In-Chull Hong, "Desensitization for Allergic Reactions to Chemotherapy", Yonsei Medical Journal, 60(2), pp.119~125 (2019), 연세대학교의과대학[DOI]
- Siripassorn K, "Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs", Int J Infect Dis, 68, pp.61~68 (2018)
- Ban GY, "Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications", Respir Med, 147, pp.44~50 (2019)
- Caiado J, "Drug desensitizations for chemotherapy : safety and efficacy in preventing anaphylaxis", Curr Allergy Asthma Rep, 21, pp.37~ (2021)
- Markman M, "Clinical features of hypersensitivity reactions to carboplatin", J Clin Oncol, 17, pp.1141~ (1999)
- Weiss RB, "Hypersensitivity reactions from taxol", J Clin Oncol, 8, pp.1263~1268 (1990)
- Markman M, "Paclitaxel-associated hypersensitivity reactions : experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center", J Clin Oncol, 18, pp.102~105 (2000)
- 이서영, "항암제 과민반응에 대한 탈감작요법의 최신지견", Allergy Asthma & Respiratory Disease, 1(4), pp.295~302 (2013), 대한 소아알레르기 호흡기학회
- Cortijo-Cascajares S, "Effectiveness of oxaliplatin desensitization protocols", Clin Transl Oncol, 15, pp.219~225 (2013)
- Lee CW, "Carboplatin hypersensitivity : a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell", IgE-mediated reactions, 2004, pp.95, 370~376
- Lee CW, "Rapid inpatient", outpatient desensitization for chemotherapy hypersensitivity : standard protocol effective in 57 patients for 255 courses, 2005, pp.99, 393~399
- Lax T, "Skin testing in the evaluation and management of carboplatin-related hypersensitivity reactions", J Allergy Clin Immunol Pract, 3, pp.856~862 (2015)
- Dye D, "Suspected anaphylactic reaction to Cremophor EL", Br Med J, 280, pp.1353~ (1980)
- Castells MC, "Hypersensitivity reactions to chemotherapy : outcomes and safety of rapid desensitization in 413 cases", J Allergy Clin Immunol, 122, pp.574~580 (2008)
- Feldweg AM, "Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel : a new standard protocol used in 77 successful treatments", Gynecol Oncol, 96, pp.824~829 (2005)
- Sloane D, "Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies", J Allergy Clin Immunol Pract, 4, pp.497~504 (2016)
- Lee JH, "A one-bag rapid desensitization protocol for paclitaxel hypersensitivity : a noninferior alternative to a multi-bag rapid desensitization protocol", J Allergy Clin Immunol Pract, 8, pp.696~703 (2020)
- Chung SJ, "A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity", Cancer Chemother Pharmacol, 82, pp.777~785 (2018)
- 김현화, "Rituximab 과민반응 환자에서의 단일 농도 탈감작 프로토콜과 단계별 희석 탈감작 프로토콜의 비교", Allergy Asthma & Respiratory Disease, 8(3), pp.135~141 (2020), 대한 소아알레르기 호흡기학회[DOI]
- 이수호, "Rituximab 지연성과민반응에 대한 신속 탈감작 적용 1예", Allergy Asthma & Respiratory Disease, 7(2), pp.109~112 (2019), 대한 소아알레르기 호흡기학회
- Cernadas JR, "General considerations on rapid desensitization for drug hypersensitivity : a consensus statement", Allergy, 65, pp.1357~1366 (2010)
- Stark BJ, "Acute and chronic desensitization of penicillin-allergic patients using oral penicillin", J Allergy Clin Immunol, 79, pp.523~532 (1987)
- Wendel GD Jr, "Penicillin allergy and desensitization in serious infections during pregnancy", N Engl J Med, 312, pp.1229~1232 (1985)
- Ghosal S, "Intravenous desensitization to ceftazidime in cystic fibrosis patients", J Antimicrob Chemother, 39, pp.556~557 (1997)
- Papakonstantinou G, "Cefotaxime desensitization", Clin Investig, 71, pp.165~167 (1993)
- Win PH, "Rapid intravenous cephalosporin desensitization", J Allergy Clin Immunol, 116, pp.225~228 (2005)
- Wilson DL, "Successful meropenem desensitization in a patient with cystic fibrosis", Ann Pharmacother, 37, pp.1424~1428 (2003)
- Marcos C, "Clindamycin desensitization in an AIDS patient", AIDS, 9, pp.1201~1202 (1995)
- Swamy N, "Successful clarithromycin desensitization in a multiple macrolide-allergic patient", Ann Allergy Asthma Immunol, 105, pp.489~490 (2010)
- Earl HS, "Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics", J Allergy Clin Immunol, 79, pp.477~483 (1987)
- Fernando SL, "Rapid desensitization to doxycycline", Ann Allergy Asthma Immunol, 111, pp.73~74 (2013)
- Gea-Banacloche JC, "Ciprofloxacin desensitization", J Allergy Clin Immunol, 97, pp.1426~1427 (1996)
- Lin RY, "Desensitization in the management of vancomycin hypersensitivity", Arch Intern Med, 150, pp.2197~2198 (1990)
- Anne S, "Vancomycin anaphylaxis and successful desensitization", Ann Allergy, 73, pp.402~404 (1994)
- Lerner A, "Desensitization to vancomycin", Ann Intern Med, 100, pp.157~ (1984)
- Shadur B, "Desensitisation to liposomal amphotericin B", J Allergy Clin Immunol Pract, 5, pp.181~183 (2017)
- Randolph C, "Rapid desensitization to fluconazole(Diflucan)", Ann Allergy Asthma Immunol, 100, pp.616~617 (2008)
- Douglas R, "Desensitization to itraconazole", J Allergy Clin Immunol, 99, pp.269~ (1997)
- Jean T, "Successful desensitization of voriconazole in an immunosuppressed pediatric patient", J Allergy Clin Immunol Pract, 3, pp.637~638 (2015)
- Seki JT, "Recurrent body rash warranted second desensitization with acyclovir in a myeloma patient : a case report", J Clin Med Res, 9, pp.725~728 (2017)
- Gonzalez-Estrada A, "Novel valganciclovir desensitization protocol", Transplantation, 98, pp.e50~e51 (2014)
- Ladd AM, "Successful desensitization to ribavirin in a patient with chronic hepatitis C", J Clin Gastroenterol, 46, pp.716~717 (2012)
- 허연정, "Fluconazole 지연형 과민반응에 대한 성공적인 탈감작 사례 1예", Allergy Asthma & Respiratory Disease, 6(1), pp.68~71 (2018), 대한 소아알레르기 호흡기학회[DOI]
- 박재석, "결핵의 치료지침", 대한내과학회지, 82(3), pp.269~273 (2012), 대한내과학회
- Bernard Yu-Hor Thong, "Update on the Management of Antibiotic Allergy", Allergy, Asthma & Immunology Research, 2(2), pp.77~86 (2010), 대한천식알레르기학회
- Kobashi Y, "Desensitization therapy for allergic reactions to antituberculous drugs", Intern Med, 49, pp.2297~2301 (2010)
- 문성도, "이차 항결핵제에 약물과민반응증후군을 보인 다제내성 결핵 환자에서 급속 탈감작요법에 준한 항결핵제 재투여 1예", Allergy Asthma & Respiratory Disease, 3(4), pp.297~301 (2015), 대한 소아알레르기 호흡기학회[DOI]
- Oh JH, "Reintroduction of antituberculous drugs in patients with antituberculous drug-related drug reaction with eosinophilia and systemic symptoms", J Allergy Clin Immunol Pract, 9, pp.3442~3449 (2021)
- Holland CL, "Rapid oral desensitization to isoniazid and rifampin", Chest, 98, pp.1518~1519 (1990)
- Thong BY, "A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy", Asia Pac Allergy, 4, pp.156~163 (2014)
- Wan Yin Winnie Yeung, "Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity", Yonsei Medical Journal, 61(1), pp.4~14 (2020), 연세대학교의과대학[DOI]
- Widal F, "First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome(plus urticaria) : 1922(with a note on aspirin desensitization). By F. Widal, P. Abrami, J. Lermoyez", J Asthma, 24, pp.297~300 (1987)
- DeGregorio GA, "A 1-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease", J Allergy Clin Immunol Pract, 7, pp.1174~1180 (2019)
- Kowalski ML, "Diagnosis and management of NSAID-Exacerbated Respiratory Disease(N-ERD) : a EAACI position paper", Allergy, 74, pp.28~39 (2019)
- Stevenson DD, "Selection of patients for aspirin desensitization treatment", J Allergy Clin Immunol, 118, pp.801~804 (2006)
- Woessner KM, "Aspirin desensitization for cardiovascular disease", Curr Opin Allergy Clin Immunol, 15, pp.314~322 (2015)
- Lee TH, "Leukotrienes and aspirin induced asthma", Thorax, 48, pp.1189~1190 (1993)
- Cortellini G, "Aspirin challenge and desensitization : how, when and why", Curr Opin Allergy Clin Immunol, 17, pp.247~254 (2017)
- Bianco S, "Aspirin induced tolerance in aspirin-asthma detected by a new challenge test", IRCS J Med Sci, 5, pp.129~ (1977)
- Zeiss CR, "Refractory period to aspirin in a patient with aspirin-induced asthma", J Allergy Clin Immunol, 57, pp.440~448 (1976)
